2 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Lynch Syndrome: new trials by email Literature Review of Lynch Syndrome trials Research Report on Lynch Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventive Dendritic Cell Vaccination for Lynch Syndrome Carriers Arm A: DC vaccination, Arm B: Placebo vaccination - Lynch Syndrome | Phase 3 | Not yet recruiting | Radboud University Medical Center | 372 | 2026-10-01 | 2026-05-27 |
| PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients PD-1 Antibody - Lynch Syndrome | Phase 3 | Unknown | Sun Yat-sen University | 260 | 2020-11-01 | 2021-01-20 |
| Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome Acetylsalicylic acid lysinate 300 mg, Placebo (for Aspirin 300), Acetylsalicylic acid lysinate 100 mg - Lynch Syndrome | Phase 3 | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 852 | 2017-11-14 | 2025-07-08 |
| Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Atezolizumab, Biospecimen Collection, Computed Tomography - Colon Adenocarcinoma, DNA Repair Disorder | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 712 | 2017-10-16 | 2026-11-13 |
| The Cancer of the Pancreas Screening-5 CAPS5)Study Secretin, MRI, Tumor marker gene test with CA19-9 - Pancreas Cancer, Peutz-Jeghers Syndrome (PJS) | Phase 3 | Recruiting | Johns Hopkins University | 9000 | 2014-01-06 | 2026-10-22 |
Colorectal Neoplasms, Hereditary Nonpolyposis (5) · Breast Neoplasms (1) · Colonic Neoplasms (1) · DNA Repair-Deficiency Disorders (1) · Dysplastic Nevus Syndrome (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Hereditary pancreatitis (1) · Pancreatic Neoplasms (1) · Peutz-Jeghers Syndrome (1)
Colonic Diseases (5) · Colorectal Neoplasms (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Gastrointestinal Diseases (5) · Gastrointestinal Neoplasms (5) · Genetic Diseases, Inborn (5) · Intestinal Diseases (5) · Intestinal Neoplasms (5) · Metabolic Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Neoplastic Syndromes, Hereditary (5) · Nutritional and Metabolic Diseases (5)
CA-19-9 Antigen (1) · Fluorouracil (1) · Leucovorin (1) · Magnetic Resonance Spectroscopy (1) · Oxaliplatin (1) · Secretin (1) · Specimen Handling (1) · acetylsalicylic acid lysinate (1) · atezolizumab (1) · dehydroftorafur (1) · spartalizumab (1) · toripalimab (1)
Assistance Publique - Hôpitaux de Paris (1) · Johns Hopkins University (1) · National Cancer Institute (NCI) (1) · Radboud University Medical Center (1) · Sun Yat-sen University (1)
United States (2) · China (1) · France (1) · Germany (1) · Netherlands (1) · Puerto Rico (1)
Frank A Sinicrope (1) · Michael Goggins, MD (1) · Peirong Ding, MD, Ph D (1)
PMID 31197699, PMID 31676359, PMID 32887653, PMID 33161160, PMID 34149034, PMID 40953502, PMID 41880612
R01CA176828 (1), U01CA210170 (1), U10CA180821 (1)